Insider Insights
21.11.2023
World’s first CRISPR medicine approved in UK for...

The MHRA grants conditional approval to Casgevy, the first-ever CRISPR gene-editing therapy for sick...

Read more
Insider Insights
21.11.2023
Landmark deal reached on UK voluntary rebate schem...

Government, NHS, and Pharma Industry Unveil Successor to Voluntary Scheme for Branded Medicines Pric...

Read more
Insider Insights
06.10.2023
Germany’s Health Ministry Shifts Focus to Di...

Germany is reshaping its Ministry of Health to prioritize the prevention of diseases like cancer, de...

Read more
Insider Insights
02.10.2023
AIFA Reform: CPR and CTS committees extended again

Discover the latest developments in AIFA reform as delays persist with the extension of CTS and CPR ...

Read more
Insider Insights
29.09.2023
Switzerland's 2024 Medicine Access Reforms

Switzerland is set to make significant changes in 2024 to enhance access to medicines, cut costs, an...

Read more
Insider Insights
21.09.2023
France's €1B 2024 Reimbursement Savings Goal

French government's ambitious plan to save €1 billion in healthcare expenses by 2024 through new r...

Read more
Insider Insights
14.09.2023
AMR Subscription Model Consultation by NHS England

Learn about the ground breaking consultation by NHS England and NICE on expanding the Antimicrobial ...

Read more
Insider Insights
12.09.2023
New Additions to HTA International Collaboration

In a ground breaking move, the international collaboration among six prominent health technology ass...

Read more
Insider Insights
29.08.2023
CMS announces first 10 drugs to undergo price nego...

The Centers for Medicare and Medicaid Services has unveiled a list of 10 drugs to undergo Medicare p...

Read more
Insider Insights
17.08.2023
Managed entry agreements: €195m saved by the Ita...

MEAs resulted in 195.2 million of savings for the Italian healthcare system, according to AIFA’s M...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.